Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: WeissLaw LLP Reminds BDSI, FTSI, CCMP, and FLOW Shareholders About Its Ongoing Investigations

BDSI

NEW YORK, Feb. 21, 2022 /PRNewswire/ --

(PRNewsfoto/WeissLaw LLP)

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioDelivery Sciences International, Inc. (NASDAQ: BDSI), in connection with the proposed acquisition of BDSI by Collegium Pharmaceutical, Inc. via a tender offer. Under the terms of the acquisition agreement, BDSI's shareholders will receive $5.60 in cash for each share of BDSI common stock that they hold. If you own BDSI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/bdsi

FTS International, Inc. (NYSE American: FTSI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of FTS International, Inc. (NYSE American: FTSI) in connection with the proposed acquisition of the company by ProFrac Holdings, LLC. Under the terms of the merger agreement, FTSI's shareholders will receive $26.52 in cash for each share of FTSI common stock that they hold. If you own FTSI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/ftsi

CMC Materials, Inc. (NASDAQ: CCMP)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CMC Materials, Inc. (NASDAQ: CCMP) in connection with the proposed acquisition of CCMP by Entegris, Inc. ("Entegris"). Pursuant to the merger agreement, CCMP stockholders will receive $133.00 in cash and 0.4506 shares of Entegris common stock for each share of CCMP common stock that they own, representing implied merger consideration of $191.66 based upon Entegris' February 18, 2022 closing price of $130.19. If you own CCMP shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/ccmp

SPX FLOW, Inc. (NYSE: FLOW)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of SPX FLOW, Inc. (NYSE: FLOW), in connection with the proposed acquisition of the company by an affiliate of Lone Star Funds. Under the terms of the merger agreement, FLOW's shareholders will receive $86.50 in cash for each share of FLOW common stock that they hold. If you own FLOW shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/flow

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-bdsi-ftsi-ccmp-and-flow-shareholders-about-its-ongoing-investigations-301486906.html

SOURCE WeissLaw LLP